alexa Nematic Protein Organization Technology: A Powerful Tool To Track Drugs Toxicity And Side Effects Already At Early Preclinical Development | 21573
ISSN: 2161-0495

Journal of Clinical Toxicology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Summit on Toxicology & Applied Pharmacology
October 20-22, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Pierre Eftekhari
ScientificTracks Abstracts: J Clin Toxicol
DOI: 10.4172/2161-0495.S1.012
Abstract
T oxicity and lack of drug efficiency from preclinical to clinical phase, are two most important hinders for development of new therapies. These are mainly due to our lack of reliable knowledge at the early stage of drug development. Another major hinder is the drugs side effect after approval, which can lead to serious or life threatening conditions. Nematic protien organization technology (NPOT) identifies both therapeutic target (ON) and toxic or side effect targets (OFF). NPOT is label free and works in physiological conditions, directly on human tissue. Where clinical relevance from genomics remains uncertain NPOT provides reliable toxicity profile identifies biomarkers and isolate success predictors. NPOT?s efficacy is shown by identifying OFF targets of two different drugs one from chloroquine family and one anti-TNFα therapy a biologic drug. They have led, at one hand to new molecule without any side effect yet improved clinical efficacy in Lupus as well as provided success predictors for anti-TNFα therapy in Inflammatory Bowel Disease (IBD). In additional thanks to NPOT we have improved our understanding on biological effects of a pharmacological active molecule at cellular and molecular levels. These findings explain the role of extracellular and intracellular matrix in expected beneficial or toxic effects. This knowledge redefines the modern pharmacology and toxicology, allowing the development of safer treatments. The author shall share these findings in detail, providing proofs and argument for the urgency to change our understanding and somehow dogmas in regard to the sciences of pharmacology and toxicology.
Biography
Pierre Eftekhari has completed his PhD from Strasbourg University. He has more than 17 years of experience in drug development and is the Director of Inoviem Scientific, a company dedicated to cutting edge solutions in drug development as well as the head of exploratory pharmaco/toxicology team at ICT, CNRS UPR 3572 Strasbourg. He has published more than 28 papers in reputed journals and filed several patents
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version